The purpose of long-term incentive plans is to generate the conditions for retaining and recruiting competent personnel to the Group and to offer employees an attractive opportunity to acquire a stake in the company, so as to encourage continued company loyalty by combining the interests of the shareholders and the employees.The programmes are thought to have a positive effect on the Group’s ongoing development and hence to be beneficial for shareholders and the company alike.
Share and related incentive plans
At the annual general meeting on May 4, 2023, new articles of association were adopted whereby the A share class was deleted and series B shares were reclassified as ordinary shares. In relation to the new incentive program that was adopted at the same annual general meeting, a new issue of 970,500 C-shares has taken place during the second quarter and of these, 105,750 have been converted into ordinary shares through the transfer of 105,750 own ordinary shares to the participants in LTIP 2023.
Medivir's holdings amount to 11,413 own ordinary shares and 864,750 own C shares in the company.
Warrants - At the beginning of the period, there were 1,587,000 outstanding warrants in the ongoing incentive programs. No changes took place during the period. The total number of outstanding warrants at the end of the period amounted to 1,587,000.